blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1706149

EP1706149 - LIPOSOME COMPOSITION FOR DELIVERY OF THERAPEUTIC AGENTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  13.11.2008
Database last updated on 14.09.2024
Most recent event   Tooltip13.11.2008Application deemed to be withdrawnpublished on 10.12.2008  [2008/50]
Applicant(s)For all designated states
ALZA Corporation
1900 Charleston Avenue, P.O. Box 7210
Mountain View, CA 94039 / US
[N/P]
Former [2006/40]For all designated states
ALZA CORPORATION
1900 Charleston Avenue, P.O. Box 7210
Mountain View, CA 94039 / US
Inventor(s)01 / ZALIPSKY, Samuel
1202 Truman Street
Redwood City, CA 94061 / US
02 / ZHANG, Weiming
731 La Playa Street C
San Francisco, CA 94121 / US
03 / HUANG, Shi, Kun
5859 Gold Creek Drive
Castro Valley, CA 94552 / US
 [2006/40]
Representative(s)Williams, Paul Edwin, et al
Ablett & Stebbing
7-8 Market Place
London W1W 8AG / GB
[N/P]
Former [2006/40]Williams, Paul Edwin, et al
Ablett & Stebbing Caparo House 101-103 Baker Street
London W1U 6FQ / GB
Application number, filing date05705796.013.01.2005
[2006/40]
WO2005US01398
Priority number, dateUS20040513864P15.01.2004         Original published format: US 513864 P
[2006/40]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005070466
Date:04.08.2005
Language:EN
[2005/31]
Type: A2 Application without search report 
No.:EP1706149
Date:04.10.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 04.08.2005 takes the place of the publication of the European patent application.
[2006/40]
Search report(s)International search report - published on:EP22.02.2007
ClassificationIPC:A61K47/48, A61K9/127
[2007/19]
CPC:
A61K9/1272 (EP,US); C07F9/09 (KR); A61K47/544 (EP,US);
A61K47/6911 (EP,US); A61K48/0008 (EP,US); A61K48/0025 (EP,US);
A61K48/0041 (EP,US); A61K9/1273 (EP,US); A61P35/00 (EP);
C07F9/08 (KR) (-)
Former IPC [2006/40]A61K47/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/40]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:LIPOSOM-ZUSAMMENSETZUNG ZUR ABGABE VON THERAPEUTISCHEN MITTELN[2006/40]
English:LIPOSOME COMPOSITION FOR DELIVERY OF THERAPEUTIC AGENTS[2006/40]
French:COMPOSITION DE LIPOSOMES POUR L'ADMINISTRATION D'AGENTS THERAPEUTIQUES[2006/40]
Entry into regional phase15.08.2006National basic fee paid 
15.08.2006Designation fee(s) paid 
15.08.2006Examination fee paid 
Examination procedure15.08.2006Examination requested  [2006/40]
21.01.2008Despatch of a communication from the examining division (Time limit: M04)
03.06.2008Application deemed to be withdrawn, date of legal effect  [2008/50]
09.07.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2008/50]
Fees paidRenewal fee
12.01.2007Renewal fee patent year 03
14.01.2008Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DX]US2003031704  (HUANG SHI-KUN [US], et al) [DX] 1-28 * the whole document *;
 [I]EP0784984  (HOFFMANN LA ROCHE [CH]) [I] 1-28 * example - * * claim - *;
 [I]EP1046394  (IMARX PHARMACEUTICAL CORP [US]) [I] 1-28 * example - * * claim - *;
 [I]WO0159156  (YISSUM RES DEV CO [IL], et al) [I] 1-28 * example - * * claims 1,9,10 *;
 [Y]WO03070220  (NOVOSOM AG [DE], et al) [Y] 1-28 * example - *;
 [Y]WO02066490  (NOVOSOM AG [DE], et al) [Y] 1-28 * example - * * claim - *;
 [I]US2001038851  (ALLEN THERESA M [CA], et al) [I] 1-28 * paragraph [0137] - paragraph [0138]; figures 5A,5B; example - *;
 [Y]  - VIGNERON J-P ET AL, "GUANIDINIUM-CHOLESTEROL CATIONIC LIPIDS: EFFICIENT VECTORS FOR THE TRANSFECTION OF EUKARYOTIC CELLS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, (19960903), vol. 93, no. 18, ISSN 0027-8424, pages 9682 - 9686, XP002030510 [Y] 1-28 * abstract * * figure - * * table 2 *

DOI:   http://dx.doi.org/10.1073/pnas.93.18.9682
 [Y]  - COLLINS D ET AL, "STRUCTURAL AND FUNCTIONAL COMPARISONS OF PH-SENSITIVE LIPOSOMES COMPOSED OF PHOSPHATIDYLETHANOLAMINE AND THREE DIFFERENT DIACYLSUCCINYLGLYCEROLS", BIOCHIMICA ET BIOPHYSICA ACTA, (1990), vol. 1025, no. 2, ISSN 0006-3002, pages 234 - 242, XP002284211 [Y] 10-28 * page 235 - page 236 * * figure - * * page 240 - page 241 *

DOI:   http://dx.doi.org/10.1016/0005-2736(90)90102-T
 [X]  - SUGAHARA M ET AL, "The importance of acyl chain placement on phospholipid mixing in the phisiologically relevant fluid phase", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (2001), vol. 123, no. 11, ISSN 0002-7863, pages 2697 - 2698, XP002411826 [X] 1-9 * page 2697, column L, paragraph L - column R, line 2 * * scheme 1 *

DOI:   http://dx.doi.org/10.1021/ja005811h
 [PX]  - MAEDA N ET AL, "Synthesis of angiogenesis-targeted peptide and hydrophobized polyethylene glycol conjugate", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (20040223), vol. 14, no. 4, ISSN 0960-894X, pages 1015 - 1017, XP002411827 [PX] 1-23 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2003.11.073
 [LX]  - MAEDA N ET AL, "Synthesis of angiogenesis-targeted peptide and hydrophobized polyethylene glycol conjugate", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 14, no. 4, (20040114), pages 1015 - 1017, URL: doi:10.1016/j.bmcl.2003.11.073, (20061214), XP002411828 [LX] 1-23 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.bmcl.2003.11.073
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.